TGFB1 and renal cell carcinoma: This finding suggested that lathyrol and paraplatin might exert their anti-RCC cell effects by influencing the synthesis and expression of the TGF-β/Smad signaling pathway proteins in RCC cells, rather than affecting the transcription of the genes of the TGF-β/Smad pathway proteins.